Skip to main content

Vaccinia Virus Genome Editing Using CRISPR

  • Protocol
  • First Online:
Vaccinia Virus

Part of the book series: Methods in Molecular Biology ((MIMB,volume 2023))

Abstract

CRISPR/Cas9, an RNA-guided targeted genome editing system, can make precise, targeted modifications to the genome in living cells. Here we describe how this method can be used to efficiently edit the vaccinia virus genome enabling the insertion of transgene(s) specifically into a targeted site.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Cooney EL, Collier AC, Greenberg PD, Coombs RW, Zarling J, Arditti DE et al (1991) Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein. Lancet 337:567–572

    Article  CAS  Google Scholar 

  2. Di Paola RS, Chen Y, Bubley GJ, Stein MN, Hahn NM, Carducci MA et al (2014) A national multicenter phase 2 study of prostate-specific antigen (PSA) pox virus vaccine with sequential androgen ablation therapy in patients with PSA progression: ECOG 9802. Eur Urol 68(3):372–373

    Google Scholar 

  3. Guo ZS, Bartlett DL (2004) Vaccinia as a vector for gene delivery. Expert Opin Biol Ther 4:901–917

    Article  CAS  Google Scholar 

  4. Moss B (2013) Reflections on the early development of poxvirus vectors. Vaccine 31:4220–4222

    Article  Google Scholar 

  5. Nakano E, Panicali D, Paoletti E (1982) Molecular genetics of vaccinia virus: demonstration of marker rescue. Proc Natl Acad Sci U S A 79:1593–1596

    Article  CAS  Google Scholar 

  6. Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N et al (2013) Multiplex genome engineering using CRISPR/Cas systems. Science 339:819–823

    Article  CAS  Google Scholar 

  7. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E (2012) A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337:816–821

    Article  CAS  Google Scholar 

  8. Yuan M, Zhang W, Wang J, Al Yaghchi C, Ahmed J, Chard L et al (2015) Efficiently editing the vaccinia virus genome by using the CRISPR-Cas9 system. J Virol 89:5176–5179

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yaohe Wang .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Di Gioia, C., Yuan, M., Wang, Y. (2019). Vaccinia Virus Genome Editing Using CRISPR. In: Mercer, J. (eds) Vaccinia Virus. Methods in Molecular Biology, vol 2023. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9593-6_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-9593-6_6

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-4939-9592-9

  • Online ISBN: 978-1-4939-9593-6

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics